GGrantIndex
← Leaderboards

Abhinav Diwan

St. Louis Va Medical Center

Google Scholar ↗PubMed ↗ORCID ↗
$10,956,125
Attributed
$15,080,125
Total exposure
11
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY2009–25
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,080,125 · 6
VA$0 · 5

By mechanism

R01$11,927,374 · 4
T32$2,916,501 · 1
R56$236,250 · 1
I01$0 · 5

Top collaborators

Most similar at St. Louis Va Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Lysosomes”

Research focus

LysosomesPreventImpairmentHeart FailureMyocardiumPathway InteractionsCardiacCardiac MyocytesAutophagocytosisStressMitochondriaCellsAdultAblationCardiomyopathiesOverexpressionHeartMyocardial IschemiaMediatingReperfusion InjuryProteinsCessation Of LifeCell DeathStructure

Grant awards (49)

LRRC8 complex regulation of endothelial function$567,143
R01 · FY2025 · HL
Mitophagy and Cardiac Myocyte Protein Aggregation$491,458
R01 · FY2025 · HL · contact PI
Principles in Cardiovascular Research Training Program$302,592
T32 · FY2025 · HL · contact PI
Mitophagy pathways in cellular cross-talk in the myocardium$0
I01 · FY2025 · VA · contact PI
Principles in Cardiovascular Research Training Program$562,535
T32 · FY2024 · HL · contact PI
LRRC8 complex regulation of endothelial function$555,801
R01 · FY2024 · HL
Mitophagy and Cardiac Myocyte Protein Aggregation$467,850
R01 · FY2024 · HL · contact PI
Mitophagy pathways in cellular cross-talk in the myocardium$0
I01 · FY2024 · VA · contact PI
LRRC8 complex regulation of endothelial function$573,879
R01 · FY2023 · HL
Principles in Cardiovascular Research Training Program$539,491
T32 · FY2023 · HL · contact PI
Mitophagy and Cardiac Myocyte Protein Aggregation$494,061
R01 · FY2023 · HL · contact PI
Autophagy in Myocardial Recovery and Remission$0
I01 · FY2023 · VA · contact PI
Mitophagy pathways in cellular cross-talk in the myocardium$0
I01 · FY2023 · VA · contact PI
Principles in Cardiovascular Research Training Program$525,585
T32 · FY2022 · HL · contact PI
Harnessing the Lysosome Machinery to Counter Metal Toxicity$236,250
R56 · FY2022 · ES
Maternal obesity and cardiometabolic health in the offspring$606,213
R01 · FY2021 · HL · contact PI
Principles in Cardiovascular Research Training Program$501,928
T32 · FY2021 · HL · contact PI
Targeting TFEB To Microglia and Monocytes to Enhance Amyloid Degradation$460,661
R01 · FY2021 · NS
Targeting Macrophage Lysosome Biogenesis Program in Cardiomyopathy and Heart Failure$0
I01 · FY2021 · VA · contact PI
Maternal obesity and cardiometabolic health in the offspring$608,561
R01 · FY2020 · HL · contact PI
Targeting TFEB To Microglia and Monocytes to Enhance Amyloid Degradation$470,580
R01 · FY2020 · NS
Innate Immunity Pathways in Autophagy Signaling in Cardiac Myocytes$396,898
R01 · FY2020 · HL · contact PI
Principles in Cardiovascular Research Training Program$184,624
T32 · FY2020 · HL · contact PI
Targeting Macrophage Lysosome Biogenesis Program in Cardiomyopathy and Heart Failure$0
I01 · FY2020 · VA · contact PI
Maternal obesity and cardiometabolic health in the offspring$608,158
R01 · FY2019 · HL · contact PI
Targeting TFEB To Microglia and Monocytes to Enhance Amyloid Degradation$478,649
R01 · FY2019 · NS
Innate Immunity Pathways in Autophagy Signaling in Cardiac Myocytes$394,417
R01 · FY2019 · HL · contact PI
Principles in Cardiovascular Research Training Program$299,746
T32 · FY2019 · HL · contact PI
Targeting Macrophage Lysosome Biogenesis Program in Cardiomyopathy and Heart Failure$0
I01 · FY2019 · VA · contact PI
Maternal obesity and cardiometabolic health in the offspring$634,724
R01 · FY2018 · HL
Targeting TFEB To Microglia and Monocytes to Enhance Amyloid Degradation$488,573
R01 · FY2018 · NS
Innate Immunity Pathways in Autophagy Signaling in Cardiac Myocytes$419,386
R01 · FY2018 · HL · contact PI
Targeting Macrophage Lysosome Biogenesis Program in Cardiomyopathy and Heart Failure$0
I01 · FY2018 · VA · contact PI
Targeting TFEB To Microglia and Monocytes to Enhance Amyloid Degradation$495,625
R01 · FY2017 · NS
Innate Immunity Pathways in Autophagy Signaling in Cardiac Myocytes$422,727
R01 · FY2017 · HL · contact PI
Innate Immunity Pathways in Autophagy Signaling in Cardiac Myocytes$36,753
R01 · FY2017 · HL · contact PI
Enhancing Beneficial Autophagy to Prevent Heart Failure$0
I01 · FY2017 · VA · contact PI
Innate Immunity Pathways in Autophagy Signaling in Cardiac Myocytes$386,797
R01 · FY2016 · HL · contact PI
Enhancing Beneficial Autophagy to Prevent Heart Failure$0
I01 · FY2016 · VA · contact PI
ROLE OF AUTOPHAGIC FLUX IN CARDIAC MYOCYTE VIABILITY$374,300
R01 · FY2015 · HL · contact PI
Enhancing Beneficial Autophagy to Prevent Heart Failure$0
I01 · FY2015 · VA · contact PI
ROLE OF AUTOPHAGIC FLUX IN CARDIAC MYOCYTE VIABILITY$372,400
R01 · FY2014 · HL · contact PI
Enhancing Beneficial Autophagy to Prevent Heart Failure$0
I01 · FY2014 · VA · contact PI
ROLE OF AUTOPHAGIC FLUX IN CARDIAC MYOCYTE VIABILITY$361,760
R01 · FY2013 · HL · contact PI
ROLE OF AUTOPHAGIC FLUX IN CARDIAC MYOCYTE VIABILITY$380,000
R01 · FY2012 · HL · contact PI
ROLE OF AUTOPHAGIC FLUX IN CARDIAC MYOCYTE VIABILITY$380,000
R01 · FY2011 · HL · contact PI
Targeting Cell Death to Prevent Ventricular Remodeling and Heart Failure$0
I01 · FY2011 · VA · contact PI
Targeting Cell Death to Prevent Ventricular Remodeling and Heart Failure$0
I01 · FY2011 · VA · contact PI
Targeting Cell Death to Prevent Ventricular Remodeling and Heart Failure$0
I01 · FY2009 · VA · contact PI